← Leaderboards
Arvind Panday
Beth Israel Deaconess Medical Center
$946,094
Attributed
$946,094
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $348.5K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$946,094 · 2
By mechanism
R00$747,000 · 1
K99$199,094 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Elliot Chaikof$40,570,541
- Ming Hui Chen$4,823,776
- Linus Tzu-Yen Tsai$3,661,867
- David McDermott$9,360,637
- Alex Toker$16,651,718
Others in their field
Other Rising Stars on “Gene Conversion”
- Nathan Schuldt · University Of Minnesota$2,999,774
- Tere M. Williams · Dub Therapeutics Inc.$2,627,211
- Michael P Weiner · Abbratech, Inc.$2,160,480
- Chrysothemis Brown · Sloan-Kettering Inst Can Research$2,124,000
- Arkarup Banerjee · Cold Spring Harbor Laboratory$2,119,145
- Mariana Xavier Byndloss · Vanderbilt University Medical Center$1,942,008
Research focus
Gene ConversionFanconi&AposCancer Cell LineBiochemicalCancer CellCancer TherapyCellsChromatinBrca1 GeneChromosomesChromosome StructuresCancer PredispositionCrispr/Cas TechnologyCytogeneticsDefectDna DamageDna Replication ForkDna StructureCancer GenomeEnvironmentEscherichia ColiEventFancd2 ProteinGenes
Grant awards (5)
Therapeutic potential of FANCM for BRCA1-linked cancer$249,000
R00 · FY2025 · CA · contact PI
Therapeutic potential of FANCM for BRCA1-linked cancer$249,000
R00 · FY2024 · CA · contact PI
Therapeutic potential of FANCM for BRCA1-linked cancer$249,000
R00 · FY2023 · CA · contact PI
Therapeutic potential of FANCM for BRCA1-linked cancer$99,547
K99 · FY2023 · CA · contact PI
Therapeutic potential of FANCM for BRCA1-linked cancer$99,547
K99 · FY2022 · CA · contact PI